Atezolizumab - auch im frühen Stadium eine effektive Option
Crossref DOI link: https://doi.org/10.1007/s15033-023-3467-7
Published Online: 2023-02-28
Published Print: 2023-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pohlmann, Birgit-Kristin
Text and Data Mining valid from 2023-02-28
Version of Record valid from 2023-02-28
Article History
First Online: 28 February 2023